246 related articles for article (PubMed ID: 29745322)
1. Metabolic Routes in Inflammation: The Citrate Pathway and its Potential as Therapeutic Target.
Infantino V; Pierri CL; Iacobazzi V
Curr Med Chem; 2019; 26(40):7104-7116. PubMed ID: 29745322
[TBL] [Abstract][Full Text] [Related]
2. ATP citrate lyase (ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism.
Granchi C
Eur J Med Chem; 2018 Sep; 157():1276-1291. PubMed ID: 30195238
[TBL] [Abstract][Full Text] [Related]
3. New Insights into Behçet's Syndrome Metabolic Reprogramming: Citrate Pathway Dysregulation.
Santarsiero A; Leccese P; Convertini P; Padula A; Abriola P; D'Angelo S; Bisaccia F; Infantino V
Mediators Inflamm; 2018; 2018():1419352. PubMed ID: 30050389
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of ATP citrate lyase induces an anticancer effect via reactive oxygen species: AMPK as a predictive biomarker for therapeutic impact.
Migita T; Okabe S; Ikeda K; Igarashi S; Sugawara S; Tomida A; Taguchi R; Soga T; Seimiya H
Am J Pathol; 2013 May; 182(5):1800-10. PubMed ID: 23506848
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis for acetyl-CoA production by ATP-citrate lyase.
Wei X; Schultz K; Bazilevsky GA; Vogt A; Marmorstein R
Nat Struct Mol Biol; 2020 Jan; 27(1):33-41. PubMed ID: 31873304
[TBL] [Abstract][Full Text] [Related]
6. Structure of ATP citrate lyase and the origin of citrate synthase in the Krebs cycle.
Verschueren KHG; Blanchet C; Felix J; Dansercoer A; De Vos D; Bloch Y; Van Beeumen J; Svergun D; Gutsche I; Savvides SN; Verstraete K
Nature; 2019 Apr; 568(7753):571-575. PubMed ID: 30944476
[TBL] [Abstract][Full Text] [Related]
7. Polarization of Human Macrophages by Interleukin-4 Does Not Require ATP-Citrate Lyase.
Namgaladze D; Zukunft S; Schnütgen F; Kurrle N; Fleming I; Fuhrmann D; Brüne B
Front Immunol; 2018; 9():2858. PubMed ID: 30568658
[TBL] [Abstract][Full Text] [Related]
8. Targeting mitochondrial citrate transport in breast cancer cell lines.
Ozkaya AB; Ak H; Atay S; Aydin HH
Anticancer Agents Med Chem; 2015; 15(3):374-81. PubMed ID: 25511512
[TBL] [Abstract][Full Text] [Related]
9. Acetylation of human mitochondrial citrate carrier modulates mitochondrial citrate/malate exchange activity to sustain NADPH production during macrophage activation.
Palmieri EM; Spera I; Menga A; Infantino V; Porcelli V; Iacobazzi V; Pierri CL; Hooper DC; Palmieri F; Castegna A
Biochim Biophys Acta; 2015 Aug; 1847(8):729-38. PubMed ID: 25917893
[TBL] [Abstract][Full Text] [Related]
10. Phenolic Compounds of Red Wine
Santarsiero A; Convertini P; Vassallo A; Santoro V; Todisco S; Iacobazzi D; Fondufe-Mittendorf Y; Martelli G; de Oliveira MR; Montanaro R; Brancaleone V; Stöckl J; Infantino V
Oxid Med Cell Longev; 2021; 2021():5533793. PubMed ID: 34122722
[TBL] [Abstract][Full Text] [Related]
11. ATP-citrate lyase regulates cellular senescence via an AMPK- and p53-dependent pathway.
Lee JH; Jang H; Lee SM; Lee JE; Choi J; Kim TW; Cho EJ; Youn HD
FEBS J; 2015 Jan; 282(2):361-71. PubMed ID: 25367309
[TBL] [Abstract][Full Text] [Related]
12. ATP citrate lyase: A central metabolic enzyme in cancer.
Icard P; Wu Z; Fournel L; Coquerel A; Lincet H; Alifano M
Cancer Lett; 2020 Feb; 471():125-134. PubMed ID: 31830561
[TBL] [Abstract][Full Text] [Related]
13. Polyamine regulating protein antizyme binds to ATP citrate lyase to accelerate acetyl-CoA production in cancer cells.
Tajima A; Murai N; Murakami Y; Iwamoto T; Migita T; Matsufuji S
Biochem Biophys Res Commun; 2016 Mar; 471(4):646-51. PubMed ID: 26915799
[TBL] [Abstract][Full Text] [Related]
14. An allosteric mechanism for potent inhibition of human ATP-citrate lyase.
Wei J; Leit S; Kuai J; Therrien E; Rafi S; Harwood HJ; DeLaBarre B; Tong L
Nature; 2019 Apr; 568(7753):566-570. PubMed ID: 30944472
[TBL] [Abstract][Full Text] [Related]
15. The role of ATP citrate-lyase in the metabolic regulation of plasma lipids. Hypolipidaemic effects of SB-204990, a lactone prodrug of the potent ATP citrate-lyase inhibitor SB-201076.
Pearce NJ; Yates JW; Berkhout TA; Jackson B; Tew D; Boyd H; Camilleri P; Sweeney P; Gribble AD; Shaw A; Groot PH
Biochem J; 1998 Aug; 334 ( Pt 1)(Pt 1):113-9. PubMed ID: 9693110
[TBL] [Abstract][Full Text] [Related]
16. ATP-citrate lyase multimerization is required for coenzyme-A substrate binding and catalysis.
Bazilevsky GA; Affronti HC; Wei X; Campbell SL; Wellen KE; Marmorstein R
J Biol Chem; 2019 May; 294(18):7259-7268. PubMed ID: 30877197
[TBL] [Abstract][Full Text] [Related]
17. ACSS2-mediated acetyl-CoA synthesis from acetate is necessary for human cytomegalovirus infection.
Vysochan A; Sengupta A; Weljie AM; Alwine JC; Yu Y
Proc Natl Acad Sci U S A; 2017 Feb; 114(8):E1528-E1535. PubMed ID: 28167750
[TBL] [Abstract][Full Text] [Related]
18. A Role for the Krebs Cycle Intermediate Citrate in Metabolic Reprogramming in Innate Immunity and Inflammation.
Williams NC; O'Neill LAJ
Front Immunol; 2018; 9():141. PubMed ID: 29459863
[TBL] [Abstract][Full Text] [Related]
19. ATP citrate lyase inhibitors as novel cancer therapeutic agents.
Zu XY; Zhang QH; Liu JH; Cao RX; Zhong J; Yi GH; Quan ZH; Pizzorno G
Recent Pat Anticancer Drug Discov; 2012 May; 7(2):154-67. PubMed ID: 22339355
[TBL] [Abstract][Full Text] [Related]
20. The multifaceted therapeutic value of targeting ATP-citrate lyase in atherosclerosis.
Verberk SGS; Kuiper KL; Lauterbach MA; Latz E; Van den Bossche J
Trends Mol Med; 2021 Dec; 27(12):1095-1105. PubMed ID: 34635427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
